STOCK TITAN

Pitanium Limited (PTNM) Financials

PTNM
FY2025 annual
Revenue $8.5M YoY not available
Net Income -$2.7M YoY not available
EPS (Diluted) -$0.12 YoY not available
Free Cash Flow -$3.5M YoY not available
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Sep 30, 2025 Reported Currency USD FYE September

Newest figures come from the 20-F for FY2025, filed Jan 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PTNM SEC filings page.

Pitanium Limited (PTNM) reported $8.5M in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PTNM FY2025

A high-gross-margin business is currently consumed by operating overhead, with financing cash flow bridging persistent operating cash needs.

The core issue is expense absorption: an 83.0% gross margin still becomes a -37.7% operating margin, showing that costs below production consume the gross-profit cushion. SG&A of $6.8M nearly matches gross profit of $7.0M, so the constraint is overhead absorption rather than the reported cost of revenue.

Cash conversion is weaker than the net loss alone suggests: net income was -$2.7M while operating cash flow was -$3.4M, meaning the income statement loss did not capture the full year's cash use. Free cash flow of -$3.5M was close to operating cash flow, so capital expenditures of $136K were a minor addition rather than the main cash drain.

The balance sheet combines near-term coverage with funding activity: a 2.8x current ratio contrasts with financing cash flow of $5.9M, indicating financing inflows offset operating cash use during FY2025. Debt-to-equity was 0.5x, while the reported liquidity comparison was 15.6 months, making funding cash use more central than heavy leverage.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 26 / 100
Financial Health Score 26/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Pitanium Limited's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
8

Pitanium Limited has an operating margin of -37.7%, meaning the company loses $38 on every $100 of revenue. This results in a profitability score of 8/100.

Growth
0

Not available for Pitanium Limited, and counted as zero in the overall score.

Leverage
61

Pitanium Limited has a moderate D/E ratio of 0.49. This balance of debt and equity financing earns a leverage score of 61/100.

Liquidity
76

With a current ratio of 2.79, Pitanium Limited holds $2.79 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 76/100.

Cash Flow
6

Pitanium Limited's operations used $3.4M of cash, and capex of $136K added to the outflow, for a free cash flow shortfall of $3.5M. This results in a cash flow score of 6/100.

Returns
5

Pitanium Limited posts a -52.1% return on equity (ROE), meaning it loses $52 for every $100 of shareholders' equity. This results in a returns score of 5/100.

Altman Z-Score Safe
56.34

Pitanium Limited scores 56.34, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($239.1M) relative to total liabilities ($2.6M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Earnings Quality No Cash Backing
N/A

Pitanium Limited reported a net loss of $2.7M while operations used $3.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Pitanium Limited reported an operating loss of $3.2M against $57K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt
$4.4M

Pitanium Limited held $4.4M in cash as of Q4 2025; long-term debt is not reported for that period.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Shares Outstanding

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

PTNM Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PTNM quarterly income statement
MetricQ4'2520-F

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

PTNM Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PTNM quarterly balance sheet
MetricQ4'2520-F
Total Assets$7.7M
Current Assets$6.4M
Cash & Equivalents$4.4M
Short-Term Investments$0
Inventory$814K
Long-Term Investments$0
Total Liabilities$2.6M
Current Liabilities$2.3M
Non-Current Liabilities$261K
Total Equity$5.2M
Retained Earnings-$1.2M

Not reported in any period shown, so not listed: Accounts Receivable, Goodwill, Long-Term Debt.

PTNM Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PTNM quarterly cash flow statement
MetricQ4'2520-F

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

PTNM Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PTNM quarterly financial ratios
MetricQ4'2520-F
Current Ratio2.79
Debt-to-Equity0.49

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Frequently Asked Questions

What is Pitanium Limited's annual revenue?

Pitanium Limited (PTNM) reported $8.5M in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is Pitanium Limited profitable?

No, Pitanium Limited (PTNM) reported a net income of -$2.7M in fiscal year 2025, with a net profit margin of -31.9%.

What is Pitanium Limited's earnings per share (EPS)?

Pitanium Limited (PTNM) reported diluted earnings per share of -$0.12 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Pitanium Limited (PTNM) had EBITDA of -$2.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Pitanium Limited (PTNM) had a gross margin of 83.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Pitanium Limited (PTNM) had an operating margin of -37.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Pitanium Limited (PTNM) had a net profit margin of -31.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Pitanium Limited (PTNM) has a return on equity of -52.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Pitanium Limited (PTNM) recorded an outflow of $3.5M in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Pitanium Limited (PTNM) recorded an outflow of $3.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Pitanium Limited (PTNM) had $7.7M in total assets as of fiscal year 2025, including both current and long-term assets.

Pitanium Limited (PTNM) invested $136K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Pitanium Limited (PTNM) had a current ratio of 2.79 as of fiscal year 2025, which is generally considered healthy.

Pitanium Limited (PTNM) had a debt-to-equity ratio of 0.49 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Pitanium Limited (PTNM) had a return on assets of -35.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2025, Pitanium Limited (PTNM) held $4.4M in cash, cash equivalents and investments, and reported an operating cash outflow of $3.4M over that year. Dividing the one by the other, the reported balance equals about 16 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Pitanium Limited (PTNM) has an Altman Z-Score of 56.34, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Pitanium Limited (PTNM) reported a net loss of $2.7M while operations used $3.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Pitanium Limited (PTNM) reported an operating loss of $3.2M against $57K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Pitanium Limited (PTNM) scores 26 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top